Results 101 to 110 of about 341,161 (289)

Australian healthcare professionals' perspectives and experiences on screening and monitoring islet autoimmunity: A qualitative exploration

Diabetic Medicine, EarlyView.
Abstract Aims Islet autoantibodies characterise a period of immune‐mediated destruction preceding clinical (symptomatic) type 1 diabetes. Screening and monitoring programmes for islet autoimmunity are being planned and implemented globally. The perspectives and experiences of healthcare professionals working in paediatric screening and monitoring of ...
Mia Majstorovic, Kelly J. McGorm, John M. Wentworth, Alyssa Sawyer, Melissa Oxlad, Jennifer J. Couper   +5 more
wiley   +1 more source

Misdiagnosis of diabetic ketoacidosis: a case report

Journal of Medical Case Reports
Background Abdominal pain caused by diabetic ketoacidosis is uncommon and can easily be misdiagnosed as abdominal pain caused by ureteral stones.This case highlights the importance of distinguishing between these etiologies, particularly in patients with
Minghe Zhang, Jian Li, Lianhui Fan, Hongtao Liu   +3 more
doaj   +1 more source

Acute Kidney Injury in Children with Diabetic Ketoacidosis

مجلة الكوفة الطبية
Backgrounds and Objectives: Diabetic ketoacidosis is frequent in type I diabetic children, and as acute kidney injury has a well-known morbidity, this study aims to determine the frequency and associated factors of acute kidney injury in these children.
Anfal MB. Hamoodi, Wid Abdul Razak Asif, Bushra Jalil Salih, Tala Anwar Al Awqati   +3 more
doaj   +1 more source

Euglycemic diabetic ketoacidosis: another masquerader! [PDF]

, 2019
Euglycemic ketoacidosis is defined by the triad of euglycemia, metabolic acidosis and ketonemia or ketonuria. In the current era of diabetic management, it is a serious concern with the usage of sodium glucose co-transporter 2 (SGLT2) inhibitors ...
Thangavelu, Saravanan, Kumar, Bhargavi, Prabhakar, Rajgokul   +2 more
core   +1 more source

Participant and physician perspectives on the use of SGLT2 inhibitors in type 1 diabetes

Diabetic Medicine, EarlyView.
Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLT2i) have proven cardiorenal benefits in type 2 diabetes and are promising as adjunct‐to‐insulin therapy in participants with type 1 diabetes (T1D). However, clinical use in T1D has been limited owing to a lack of regulatory approval and the augmented risk of diabetic ketoacidosis (DKA ...
Julia Fielden, Pam Leblanc, Chloe Parezanovic, Vikas S. Sridhar, Bruce A. Perkins, David Z. Cherney, David J. T. Campbell   +6 more
wiley   +1 more source

Acute brachial artery thrombosis with diabetic ketoacidosis

, 2016
Background: Diabetes Mellitus is a worldwide disease that leads to several acute complications including diabetic ketoacidosis. Diabetic ketoacidosis is usually preceded by infection, acute myocardial infarction, stroke, or other dire ...
Syed Abdul Rahman, Neeraj Kumar, Ejaz Salam Khan   +2 more
core   +1 more source

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real‐Life Experience From a National Reference Network

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Lipodystrophy syndromes are rare diseases with metabolic and cardiovascular consequences. This study explores the metabolic and renal effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with genetic lipodystrophy. Patients and Methods Patients with familial partial lipodystrophy (n = 57) or congenital generalised ...
Léna Robert, Ines Belalem, Corinne Vigouroux, Hippolyte Dupuis, Marie Christine Vantyghem, Mathilde Simonson, Estelle Nobecourt, Héléna Mosbah, Sophie Beliard, Stéphanie Jellimann, Sonja Janmaat, Camille Vatier, Sophie Lamothe   +12 more
wiley   +1 more source

Multi‐Dimensional Barriers for Work Productivity and Possible Solutions to Overcome Presenteeism in Young‐Onset Diabetes: A Mixed‐Methods Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Young‐onset non‐type 1 diabetes (YOD, age‐at‐diagnosis ≤ 40) is associated with poor physical and mental health, presenteeism and productivity loss. We examined patient‐perceived barriers to work productivity and key enablers to reduce presenteeism. Materials and Methods In this mixed‐methods study, we utilized validated questionnaires to
Kelly T. C. Wong, Jason D. C. Yin, Sunny C. S. Chan, Nga Sze Wong, Chun‐Kwan O, Yiming Dai, Yuzheng Zhang, Marques S.N. Ng, Risa Ozaki, Ronald C. W. Ma, Alice P. S. Kong, Andrea O. Y. Luk, Elaine Y.K. Chow, Juliana C. N. Chan, Juliana N. M. Lui   +14 more
wiley   +1 more source

Diabetic ketoacidosis knowledge in type 1 diabetes: a Brazilian perspective

Archives of Endocrinology and Metabolism
Objective: To evaluate the factors associated with knowledge of diabetic ketoacidosis among individuals with type 1 diabetes mellitus and to analyze how sociodemographic, clinical, and healthcare access variables influence understanding of the condition ...
Renan Bruno Faria Pisani, Virgínia Valiate Gonzalez, Bruna Rambo Witte, Taylane Guimarães Gonçalves, Lohane Alves Santiago, Adalgiza Mafra Moreno, Rodrigo de Azeredo Siqueira   +6 more
doaj   +1 more source

Frequency of Diabetic Ketoacidosis and Severe Hypoglycemia in Children with Type 1 Diabetes

Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2022
Background and Objective: Diabetic ketoacidosis and severe hypoglycemia are common and recurrent acute complications of type 1 diabetes and are associated with high mortality and morbidity. The aim of this study was to determine the frequency of diabetic
A Homaei, F Saffari, E Parsarad, ZS Mohammadi   +3 more
doaj